heliusmedical.com (HSDT): רווח נקי למניה ב-12 החודשים האחרונים

Earnings per share over the last 12 months demonstrate the financial dynamics of Helius Medical (HSDT), where -30.51 is the current value of the metric. Management is focusing on the commercialization of non-invasive brain stimulation. The business's uniqueness is based on patents for the FDA-approved PoNS system. Production stability is ensured through buffer stocks of microchips and partnerships with proven US assemblers.

Helius Medical focuses on intellectual property, minimizing capital expenditures by outsourcing hardware production. This metric calculates the net income allocated to each common share per year, determining the actual return on an investor's stake. By analyzing the annual net income per share trend, one can assess the efficiency of external supply chain management. Growth in this indicator confirms the scalability of the model while maintaining control over the software. The stable dynamics of the curve serve as a signal for the long-term capitalization of the business.